News | Radiation Therapy | September 22, 2017

Penn Medicine Treats World's First Patient on Varian's Halcyon System

Head & neck cancer patient treated in just 13 minutes with advanced platform

Penn Medicine Treats World's First Patient on Varian's Halcyon System

September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's new Halcyon radiation therapy platform. Halcyon is well suited to handle the majority of cancer patients, according to the company, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer.

The treatment for this patient at Penn Medicine was a complex case that involved the delivery of nine fields. The total patient time in the treatment room, including set-up, imaging, three minutes of beam time and patient discharge, was only 13 minutes. Typically, a treatment like this using other radiation technology can take 10 minutes of beam time and 20 minutes total treatment time.

Halcyon is an advanced system that is more comfortable for the patient while delivering ease of use for healthcare providers, accelerated installation timeframes, expedited commissioning, simplified training and automated treatment.

"We are proud to have delivered the world's first Halcyon treatment, which contributes to our ongoing mission to provide patients the widest and most advanced array of cancer treatment options," said James Metz, M.D., chair of radiation oncology at Penn Medicine. "This platform combines reduced treatment time with simplified operation, and for some diseases, it even lets us be more precise with the radiation we're delivering."

For more information: www.varian.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...